Fresh interest in SCOR (ENXTPA:SCR) has been sparked by recent coverage highlighting its valuation metrics and earnings outlook. This has prompted investors to reassess the reinsurer’s share performance and risk profile as of early October 2026.
At a share price of €31.76, SCOR has seen short term momentum soften, with the 30 day share price return down 3.05%, even though the year to date share price return is up 12.62% and the 5 year total shareholder return is 80.29%.
Compare SCOR’s valuation reset with a curated group of other value-focused opportunities using the 179 high quality undervalued stocks as a starting list for further ideas.
The recent pullback in SCOR’s share price could be read as a simple mood shift in the market or as a signal about how investors view the reinsurer’s fundamentals. The valuation gap is where that tension shows up most clearly.
On Simply Wall St’s most followed narrative, SCOR’s fair value of €35.97 sits above the last close of €31.76. This places the recent pullback against a view that the reinsurer is still trading below assessed worth at a 6.47% discount rate.
SCOR's data-driven underwriting, strategic shift towards more profitable and diversifying lines, and consistently strong attritional loss ratio indicate it is leveraging data-driven risk selection and capitalizing on technology adoption, which should translate into sustained improvement in net margins and underwriting profitability. Ongoing geographic and business diversification including growing exposure in alternative solutions, engineering, and international casualty provides access to untapped markets, aligning with the broader trend of rising insurance penetration globally, which expands SCOR's revenue base.
See why 27 investors see SCOR as 12% undervalued.
Result: Fair Value of €35.97 (UNDERVALUED)
Still, the narrative around SCOR can shift quickly if legal outcomes from the Covéa dispute or higher catastrophe exposure begin to affect earnings quality.
Find out about the key risks to this SCOR narrative.
Mixed messages in the SCOR story so far or a clear opportunity in disguise? Act while the data is fresh and weigh both sides through the 3 key rewards and 1 important warning sign.
If SCOR has sharpened your focus on valuation and risk, do not stop here. Broaden your watchlist and give yourself more options before the next move.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com